Cytoplasmic nonsense-mediated mRNA decay for a nonsense (W262X) transcript of the gene responsible for hereditary tyrosinemia, fumarylacetoacetate hydrolase

Biochemical and Biophysical Research Communications

Volumn 324, Issue 1, 2004, Pages 186-192

  Dreumont, Natacha ^a   Maresca, Antonella ^a   Khandjian, Edward W ^b   Baklouti, Faouzi ^c   Tanguay, Robert M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

FAH; Nonsense mediated mrna decay; Tyrosinemia

Indexed keywords

FUMARYLACETOACETASE; MESSENGER RNA; PROTEIN; PROTEIN W262X; UNCLASSIFIED DRUG;

ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME DEFICIENCY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; METABOLIC DISORDER; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; TYROSINEMIA;

CELL LINE; CODON, NONSENSE; GENE EXPRESSION REGULATION; HUMANS; HYDROLASES; MUTATION; PROTEIN BIOSYNTHESIS; RNA STABILITY; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TYROSINEMIAS;

EUKARYOTA;

EID: 4744344805     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.041     Document Type: Article

References (44)

1. G.A. Mitchell, M. Grompe, M. Lambert, and R.M. Tanguay Hypertyrosinemia C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Diseases Eighth ed. 2001 McGraw-Hill New York 1777 1805
2. R. Jorquera, and R.M. Tanguay The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion Biochem. Biophys. Res. Commun. 232 1997 42 48
3. R. Jorquera, and R.M. Tanguay Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis FASEB J. 13 1999 1 15
4. R. Jorquera, and R.M. Tanguay Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability Hum. Mol. Genet. 10 2001 1741 1752
5. J. Poudrier, F. Lettre, C.R. Scriver, J. Larochelle, and R.M. Tanguay Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes Mol. Genet. Metab. 64 1998 119 125
6. E.A. Kvittingen, H. Rootwelt, R. Berger, and P. Brandtzaeg Self-induced correction of the genetic defect in tyrosinemia type I J. Clin. Invest. 94 1994 1657 1661
7. S.I. Demers, P. Russo, F. Lettre, and R.M. Tanguay Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia Hum. Pathol. 34 2003 1313 1320
8. D. Phaneuf, Y. Labelle, D. Berubé, K. Arden, M. Cavenee, R. Gagné, and R.M. Tanguay Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15 Am. J. Hum. Genet. 48 1991 525 535
9. Y. Labelle, D. Phaneuf, B. Leclerc, and R.M. Tanguay Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity Hum. Mol. Genet. 2 1993 941 946
10. M. St-Louis, and R.M. Tanguay Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview Hum. Mutat. 9 1997 291 299
11. J.A. Arranz, F. Pinol, L. Kozak, C. Perez-Cerda, B. Cormand, M. Ugarte, and E. Riudor Splicing mutations, mainly IVS6-1(G > T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients Hum. Mutat. 20 2002 180 188
12. M. St-Louis, B. Leclerc, J. Laine, M. Salo, C. Homberg, and R.M. Tanguay Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I Hum. Mol. Genet. 3 1994 69 72
13. H. Rootwelt, R. Berger, G. Gray, D.A. Kelly, T. Coskun, and E.A. Kvittingen Novel splice, missense, and nonsense mutations in the fumarylacetoacetase gene causing tyrosinemia type 1 Am. J. Hum. Genet. 55 1994 653 658
14. L.E. Maquat When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells RNA 1 1995 453 465
15. P. Hilleren, and R. Parker mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization? Annu. Rev. Genet. 33 1999 229 260
16. P.H. Byers Killing the messenger: new insights into nonsense-mediated mRNA decay J. Clin. Invest. 109 2002 3 6
17. M.R. Culbertson, and P.F. Leeds Looking at mRNA decay pathways through the window of molecular evolution Curr. Opin. Genet. Dev. 13 2003 207 214
18. K. Czaplinski, M.J. Ruiz-Echevarria, C.I. Gonzales, and S.W. Peltz Should we kill the messenger? The role of the surveillance complex in translation termination and mRNA turnover Bioessays 21 1999 668 685
19. H.A. Perlick, S. Medghalchi, F.A. Spencer, R.J. Kendzior Jr., and H.C. Dietz Mammalian orthologues of a yeast regulator of nonsense transcript stability Proc. Natl. Acad. Sci. USA 93 1996 10928 10932
20. J. Lykke-Andersen, M.D. Shu, and J.A. Steitz Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon Cell 103 2000 1121 1131
21. J. Lykke-Andersen Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay Mol. Cell. Biol. 22 2002 8114 8121
22. C.Y.A. Chen, and A.B. Shyu Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway Mol. Cell. Biol. 23 2003 4805 4813
23. F. Lejeune, X. Li, and L.E. Maquat Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities Mol. Cell 12 2003 675 687
24. J. Cheng, and L.E. Maquat Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA Mol. Cell. Biol. 13 1993 1892 1902
25. P. Belgrader, J. Cheng, X. Zhou, L.S. Stephenson, and L.E. Maquat Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life Mol. Cell. Biol. 14 1994 8219 8228
26. R. Thermann, G. Neu-Yilik, A. Deters, U. Frede, K. Wehr, C. Hagemeier, M.W. Hentze, and E.A. Kulozik Binary specification of nonsense codons by splicing and cytoplasmic translation EMBO J. 17 1998 3484 3494
27. J. Zhang, X. Sun, Y. Qian, J.P. LaDuca, and L.E. Maquat At least one intron is required for the nonsense-mediated decay of triosephosphate isomerase mRNA: a possible link between nuclear splicing and cytoplasmic translation Mol. Cell. Biol. 1 1998 5272 5283
28. L.E. Maquat, and G.G. Carmichael Quality control of mRNA function Cell 104 2001 173 176
29. M. St-Louis, J. Poudrier, and R.M. Tanguay Simple detection of a Finnish hereditary tyrosinemia type I mutation Hum. Mutat. 7 1996 379 380
30. S. Tremblay, and E.W. Khandjian Successful use of long-term frozen lymphocytes for the establishment of lymphoblastoid cell lines Clin. Biochem. 31 1998 555 556
31. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
32. K. Kusuhara, M. Anderson, S.M. Pettiford, and P.L. Green Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs J. Virol. 73 1999 8112 8119
33. R.M. Tanguay, J.P. Valet, A. Lescault, J.L. Duband, C. Laberge, F. Lettre, and M. Plante Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I) Am. J. Hum.Genet. 47 1990 308 316
34. L. Perrin-Vidoz, O.M. Sinilkova, D. Stoppa-Lyonnet, G.M. Lenoir, and S. Mazoyer The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons Hum. Mol. Genet. 11 2002 2805 2814
35. S. Li, and M.F. Wilkinson Nonsense surveillance in lymphocytes? Immunity 8 1998 135 141
36. K.S. Rajavel, and E.F. Neufeld Nonsense-mediated decay of human HEXA mRNA Mol. Cell. Biol. 21 2001 5512 5519
37. J.P. Gudikote, and M.F. Wilkinson T-cell receptor sequences that elicit strong down-regulation of premature termination codon-bearing transcripts EMBO J. 21 2002 125 134
38. S.K. Lim, C.D. Sigmund, K.W. Gross, and L.E. Maquat Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products Mol. Cell. Biol. 12 1992 1149 1161
39. P.M. Moriarty, C.C. Reddy, and L.E. Maquat Selenium deficiency reduces the abundance of mRNA for Se-dependent glutathione peroxidase 1 by a UGA-dependent mechanism likely to be nonsense codon-mediated decay of cytoplasmic mRNA Mol. Cell. Biol. 18 1998 2932 2939
40. O. Kessler, and L.A. Chasin Effects of nonsense mutations on nuclear and cytoplasmic adenine phosphoribosyltransferase RNA Mol. Cell. Biol. 16 1996 4426 4435
41. G. Urlaub, P.J. Mitchell, C.J. Ciudad, and L.A. Chasin Nonsense mutations in the dihydrofolate reductase gene affect mRNA processing Mol. Cell. Biol 9 1989 2868 2880
42. S.K. Lim, and L.E. Maquat Human β-globin mRNAs that harbor nonsense codon are degraded in murine erythroid tissues to intermediates lacking regions of exon I or exons I and II that have a cap-like structure at the 5′ termini EMBO J. 11 1992 3271 3278
43. E.N. Noensie, and H.C. Dietz A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition Nat. Biotechnol. 19 2001 434 439
44. J. Wang, V.M. Vock, S. Li, O.R. Olivas, and M.F. Wilkinson A quality control pathway that down-regulates aberrant T-cell receptor (TCR) transcripts by a mechanism requiring UPF2 and translation J. Biol. Chem. 277 2002 18489 18493